Medicus Pharma Ltd. (MDCX) analyst actions
Rating and price-target actions on MDCX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MDCX overview →
1 measured MDCX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program | Press release | -2.38% | +4.00% |
Keep exploring
More MDCX: earnings → · SEC filings → · MDCX overview →